Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors

Neuroepidemiology

Volumn 25, Issue 4, 2005, Pages 176-180

  Freedman, D Michal ^a   Travis, Lois B ^a   Gridley, Gloria ^a   Kuncl, Ralph W ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BRYN MAWR COLLEGE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cancer; Lymphoproliferative; Melanoma; Parkinson's disease; Registry; Smoking; Tobacco

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CANCER CENTER; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; DEATH CERTIFICATE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METHODOLOGY; MORTALITY; PARKINSON DISEASE; SMOKING;

AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DATABASES, FACTUAL; HUMANS; NEOPLASMS; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK ASSESSMENT; SMOKING; SURVIVORS; UNITED STATES;

EID: 27544465239     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087447     Document Type: Article

References (26)

1. Rowland LP, Shneider NA: Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700.
2. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C: Population-based case-control study of amyotropnic lateral sclerosis in Western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000;151:156-163.
3. Kamel F, Umbach DM, Munsat TL, Shefner JM, Sandler DP: Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology 1999;18:194-202.
4. Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A: Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 2004;160:26-33.
5. Chio A, Brignoho F, Meineri P, Rosso MG, Tribolo A, Schiffer D: Motor neuron disease and malignancies: results of a population-based study. J Neurol 1988;235:374-375.
6. Leone M, Chandra V, Schoenberg BS: Motor neuron disease in the United States, 1971 and 1973-1978. Neurology 1987;37:1339-1343.
7. Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Mason TJ: Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology 1983;33:911-915.
8. Kondo K: Motor neuron disease and Parkinson's disease are not associated with other disorders at autopsy. Neuroepidemiology 1984;3:182-194.
9. Kurtzke JF, Beebe GW: Epidemiology of amyotrophic lateral sclerosis. 1. A case-control comparison based on ALS deaths. Neurology 1980;30:453-462.
10. Vanacore N, Spila-Alegiani S, Raschetti R, Meco G: Mortality cancer risk in Parkinsonian patients: a population-based study. Neurology 1999;52;395.
11. Moller H, Mellemkjaer L, McLaughlin JK, Olsen JH: Occurrence of different cancers in patients with Parkinson's disease. BMJ 1995;310:1500-1501.
12. Ben-Shlomo Y, Marmot MG: Survival and cause of death in a cohort of patients with Parkinsonism: Possible clues to aetiology? J Neurol Neurosurg Psychiatry 1995;58:293-299.
13. Olsen JH, Friis S, Frederiksen K, McLauglin JK, Mellemkjaer L, Moller H: Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer 2005;92:201-205.
14. http://seer.cancer.gov (March 21, 2005).
15. Jemal A, Clegg LX, Ward E, Ries LAG, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK: Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101:3-271.
16. Swan J, Wingo P, Clive R, West D, Miller D, Hutchison C, Sondik E, Edwards BK: Cancer surveillance in the US Cancer 1998;83:1282-1291.
17. Fiala KH, Whetteckey J, Manyam BV: Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? Parkinsonism and related disorders 2003;9:321-327.
18. Nelson LM: Epidemiology of ALS. Clin Neurosci 1996;3:327-331.
19. Christiansen JH, Coles EG, Wilkinson DG: Molecular control of neural crest formation, migration and differentiation. Curr Opin Cell Biol 2000;12:719-724.
20. Tomiyama M, Kimura T, Maeda T, Tanaka H, Furusawa K, Kurahashi K, Matsunaga M: Expression of metabotropic glutamate receptor mRNAs in the human spinal cord: Implications for selective vulnerability of spinal motor neurons in amyotropic lateral sclerosis. J Neurol Sci 2001;189:65-69.
21. Frati C, Marchese C, Fisichella G, Copani A, Nasca MR, Storto M, Nicoletti F: Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. J Cell Physiol 2000;183:364-372.
22. Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, Koganti A, et al: Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia (letter). Nat Genet 2003;34;108-112.
23. Ragonese P, Filippini G, Salemi G, Beghi E, Citterio A, D'Alessandro R, Marini C, Monsurro MR, Aiello I, Morgante L, Tempestini A, Fratti C, Ragno M, Pugliatti M, Epifanio A, Testa D, Savettieri G: Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: Implications for mortality studies. Neuroepidemiology 2004;23:73-77.
24. Ragonese P, Salemi G, Aridon P, Conte S, Cuccia G, Lupo I, Savettieri G: Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in Southern Italy. Neuroepidemiology 2002;21:148-152.
25. Roman GC: Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry 1996;61:131-137.
26. Chio A, Magnani C, Oddenino E, et al: Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Commun Health 1992;46:517-518.